341 related articles for article (PubMed ID: 16700399)
41. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
42. Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies.
Huang T; Boucher K; Summers AM
Prenat Diagn; 2007 Dec; 27(12):1138-42. PubMed ID: 17960787
[TBL] [Abstract][Full Text] [Related]
43. Antenatal maternal serum profiles.
Spencer K
Br J Hosp Med; 1994 Mar 2-15; 51(5):243-6. PubMed ID: 7518729
[TBL] [Abstract][Full Text] [Related]
44. Maternal serum superoxide dismutase (SOD): a possible marker for screening Down syndrome affected pregnancies.
Ognibene A; Ciuti R; Tozzi P; Messeri G
Prenat Diagn; 1999 Nov; 19(11):1058-60. PubMed ID: 10589060
[TBL] [Abstract][Full Text] [Related]
45. Utility of the triple test in the detection of abnormalities of the feto-placental unit.
Perenc M; Dudarewicz L; Kałuzewski B
Med Sci Monit; 2000; 6(5):994-9. PubMed ID: 11208444
[TBL] [Abstract][Full Text] [Related]
46. Triple marker screening in native Japanese women.
Onda T; Kitagawa M; Takeda O; Sago H; Kubonoya K; Iinuma K; Bradley LA; Canick JA; Krasikov NE; Ponting NR; Grier RE
Prenat Diagn; 1996 Aug; 16(8):713-7. PubMed ID: 8878280
[TBL] [Abstract][Full Text] [Related]
47. Human chorionic gonadotrophin and trisomy 18.
Barkai G; Chaki R; Sochat M; Goldman B
Am J Med Genet; 1991 Oct; 41(1):52-3. PubMed ID: 1719814
[TBL] [Abstract][Full Text] [Related]
48. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
Burton BK; Prins GS; Verp MS
Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522
[TBL] [Abstract][Full Text] [Related]
49. Maternal serum screening in Ontario using the triple marker test.
Summers AM; Farrell SA; Huang T; Meier C; Wyatt PR
J Med Screen; 2003; 10(3):107-11. PubMed ID: 14561260
[TBL] [Abstract][Full Text] [Related]
50. Maternal serum screening and trisomy 16 confined to the placenta.
Groli C; Cerri V; Tarantini M; Bellotti D; Jacobello C; Gianello R; Zanini R; Lancetti S; Zaglio S
Prenat Diagn; 1996 Aug; 16(8):685-9. PubMed ID: 8878276
[TBL] [Abstract][Full Text] [Related]
51. [Triple screening for trisomy 21: prospective results of 7039 assessments].
Pescia G; Dao MH; Weihs D; Gaide AC; Loertscher A; Hohlfeld P; Marguerat P; Nguyen The H; Paccaud F; Maillard C
Rev Med Suisse Romande; 1993 Apr; 113(4):277-80. PubMed ID: 7684852
[No Abstract] [Full Text] [Related]
52. Reliability of second trimester triple screening for Down syndrome in rhesus-negative women.
Muhcu M; Mungen E; Dundar O; Bodur S; Tutuncu L; Atay V; Ozcan O; Yergok YZ
J Perinatol; 2007 May; 27(5):268-71. PubMed ID: 17363912
[TBL] [Abstract][Full Text] [Related]
53. Second trimester serum predictors of congenital heart defects in pregnancies without chromosomal or neural tube defects.
Jelliffe-Pawlowski L; Baer R; Moon-Grady AJ; Currier RJ
Prenat Diagn; 2011 May; 31(5):466-72. PubMed ID: 21351282
[TBL] [Abstract][Full Text] [Related]
54. The effectiveness of prenatal serum biomarker screening for neural tube defects in second trimester pregnant women: a meta-analysis.
Wang ZP; Li H; Hao LZ; Zhao ZT
Prenat Diagn; 2009 Oct; 29(10):960-5. PubMed ID: 19609892
[TBL] [Abstract][Full Text] [Related]
55. Biochemical screening for congenital defects.
Bahado-Singh RO; Sutton-Riley J
Obstet Gynecol Clin North Am; 2004 Dec; 31(4):857-72, xi. PubMed ID: 15550339
[TBL] [Abstract][Full Text] [Related]
56. Maternal serum screening for neural tube defects and Down's syndrome.
Robertson EF
Med J Aust; 1991 Jul; 155(2):67-8. PubMed ID: 1713290
[No Abstract] [Full Text] [Related]
57. Screening for trisomies 21 and 18 with maternal serum placental isoferritin p43 component.
Moroz C; Maymon R; Jauniaux E; Traub L; Cuckle H
Prenat Diagn; 2000 May; 20(5):395-9. PubMed ID: 10820407
[TBL] [Abstract][Full Text] [Related]
58. [Specificity of biochemical markers of pregnancy second trimester].
Salazar López R; Ibarra Gallardo AL; Iduma Meléndrez M; Leyva Bojórquez R
Ginecol Obstet Mex; 2007 Oct; 75(10):608-14. PubMed ID: 18800579
[TBL] [Abstract][Full Text] [Related]
59. Maternal serum screening for trisomy 21 in women with a false positive result in last pregnancy.
Abdul-Hamid S; Fox R; Martin I
J Obstet Gynaecol; 2004 Jun; 24(4):374-6. PubMed ID: 15203574
[TBL] [Abstract][Full Text] [Related]
60. [The use of the screening of maternal serum factors for the prenatal diagnosis of fetal developmental defects and chromosomal diseases].
Arbuzova SB; Nikolenko MI
Tsitol Genet; 1995; 29(4):44-7. PubMed ID: 8604526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
